DEERFIELD, Ill., December 11, 2001 - Baxter Healthcare Corporation announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market its HomeChoice Pediatric ...
First patients have been enrolled in the clinical trial for next generation dialysis technology Innovative system designed to improve home dialysis experience and simplify therapy management New ...
Chicago medical device startup Simergent received federal clearance for a home dialysis machine that costs up to 70% less ...
Baxter International Inc.BAX recently announced the enrollment of the first group of patients under a U.S. clinical trial for the company's flagship peritoneal dialysis (PD) solution generation system ...
With one in four APD patients globally benefitting from Baxter’s two-way remote patient management technology, Sharesource offers patients and clinicians the ability to stay closely connected to ...
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today new data associating the use of its automated peritoneal dialysis (APD) cyclers and the Sharesource remote ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Baxter International has expanded its ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced U.S. Food and Drug Administration (FDA) clearance of the Homechoice Claria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback